BRPI9813397B1 - formulação medicinal em aerossol e produto medicinal. - Google Patents

formulação medicinal em aerossol e produto medicinal.

Info

Publication number
BRPI9813397B1
BRPI9813397B1 BRPI9813397-7A BRPI9813397A BRPI9813397B1 BR PI9813397 B1 BRPI9813397 B1 BR PI9813397B1 BR PI9813397 A BRPI9813397 A BR PI9813397A BR PI9813397 B1 BRPI9813397 B1 BR PI9813397B1
Authority
BR
Brazil
Prior art keywords
medicinal
aerosol formulation
drug
product
propellant
Prior art date
Application number
BRPI9813397-7A
Other languages
English (en)
Inventor
Yvonne Mary Beatrice King
Kanwaljit Singh Claire
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of BRPI9813397A publication Critical patent/BRPI9813397A/pt
Publication of BRPI9813397B1 publication Critical patent/BRPI9813397B1/pt
Publication of BRPI9813397B8 publication Critical patent/BRPI9813397B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI9813397 1997-12-08 1998-11-20 formulação medicinal em aerossol e produto medicinal. BRPI9813397B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9725984A GB2332372B (en) 1997-12-08 1997-12-08 Pharmaceutical aerosol compositions
PCT/GB1998/003488 WO1999029296A1 (en) 1997-12-08 1998-11-20 Pharmaceutical aerosol compositions

Publications (3)

Publication Number Publication Date
BRPI9813397A BRPI9813397A (pt) 2000-10-10
BRPI9813397B1 true BRPI9813397B1 (pt) 2011-08-23
BRPI9813397B8 BRPI9813397B8 (pt) 2021-07-06

Family

ID=10823304

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9813397 BRPI9813397B8 (pt) 1997-12-08 1998-11-20 formulação medicinal em aerossol e produto medicinal.

Country Status (11)

Country Link
EP (1) EP1037604B1 (pt)
JP (1) JP5384776B2 (pt)
AT (1) ATE287699T1 (pt)
AU (1) AU759746B2 (pt)
BR (1) BRPI9813397B8 (pt)
CA (1) CA2311450C (pt)
DE (1) DE69828817T2 (pt)
ES (1) ES2234165T3 (pt)
GB (1) GB2332372B (pt)
PT (1) PT1037604E (pt)
WO (1) WO1999029296A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1547636A1 (en) * 1995-04-14 2005-06-29 SmithKline Beecham Corporation Metered dose inhaler for salmeterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6423298B2 (en) 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
JP2003509359A (ja) * 1999-09-11 2003-03-11 グラクソ グループ リミテッド プロピオン酸フルチカゾンの医薬製剤
JP2003518484A (ja) * 1999-12-24 2003-06-10 グラクソ グループ リミテッド サルメテロールおよびプロピオン酸フルチカゾンの医薬用エアゾル製剤
US20040191176A1 (en) * 2003-03-28 2004-09-30 Kaplan Leonard W Formulations for treatment of pulmonary disorders
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
PE20130036A1 (es) 2009-11-25 2013-02-03 Boehringer Ingelheim Int Nebulizador
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP3020393B1 (en) * 2009-12-16 2020-10-07 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
WO2015169732A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Container, nebulizer and use
HUE055604T2 (hu) 2014-05-07 2021-12-28 Boehringer Ingelheim Int Porlasztó
AP2016009486A0 (en) 2014-05-07 2016-10-31 Boehringer Ingelheim Int Nebulizer, indicator device and container
US12214346B2 (en) 2021-10-13 2025-02-04 Satio, Inc. Dermal patch with a diagnostic test strip
US12023156B2 (en) 2021-10-13 2024-07-02 Satio, Inc. Dermal patch for collecting a physiological sample
US12053284B2 (en) 2021-11-08 2024-08-06 Satio, Inc. Dermal patch for collecting a physiological sample
US12178979B2 (en) 2021-10-13 2024-12-31 Satio, Inc. Dermal patch for delivering a pharmaceutical
US12029562B2 (en) 2021-04-14 2024-07-09 Satio, Inc. Dermal patch system
US12048543B2 (en) 2021-11-08 2024-07-30 Satio, Inc. Dermal patch for collecting a physiological sample with removable vial
US11877848B2 (en) 2021-11-08 2024-01-23 Satio, Inc. Dermal patch for collecting a physiological sample
US11964121B2 (en) 2021-10-13 2024-04-23 Satio, Inc. Mono dose dermal patch for pharmaceutical delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2094266C (en) * 1990-10-18 1999-06-01 Robert K. Schultz Aerosol formulations of beclomethasone-17,21-dipropionate
ATE128350T1 (de) * 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
EP0914143A1 (en) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
CN1161104C (zh) * 1998-06-18 2004-08-11 贝林格尔·英格海姆药物公司 有二种或多种活性物质的气溶胶药物制剂

Also Published As

Publication number Publication date
WO1999029296A1 (en) 1999-06-17
DE69828817D1 (de) 2005-03-03
ATE287699T1 (de) 2005-02-15
CA2311450A1 (en) 1999-06-17
JP5384776B2 (ja) 2014-01-08
AU759746B2 (en) 2003-05-01
EP1037604A1 (en) 2000-09-27
JP2001525354A (ja) 2001-12-11
GB9725984D0 (en) 1998-02-04
GB2332372A (en) 1999-06-23
GB2332372B (en) 2002-08-14
DE69828817T2 (de) 2006-05-18
PT1037604E (pt) 2005-05-31
BRPI9813397A (pt) 2000-10-10
AU1248699A (en) 1999-06-28
CA2311450C (en) 2009-05-05
ES2234165T3 (es) 2005-06-16
EP1037604B1 (en) 2005-01-26
BRPI9813397B8 (pt) 2021-07-06

Similar Documents

Publication Publication Date Title
BRPI9813397B1 (pt) formulação medicinal em aerossol e produto medicinal.
ATE343374T1 (de) Fluticasonpropionat arzneizubereitung
ATE291898T1 (de) Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
NZ298169A (en) Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant
GEP20053420B (en) Sustained Release Ranolanolazine Formulation
YU59092A (sh) Formulacije aerosola koji ne sadrže hlorofluorougljenična jedinjenja
NO307864B1 (no) Farmasøytisk aerosolformulering, boks og doseringsinhalator
EP1135173A4 (en) MEDICINAL AEROSOL FORMULATION
EP1736147A3 (en) Non-chlorofluorocarbon aerosol formulations
DK1306082T3 (da) Afmålte dosisinhalatorer under tryk og farmaceutiske aerosolformuleringer
ES2107203T3 (es) Una formulacion de aerosol que contiene un adyuvante de dispersion derivado de un diol-diacido.
ES2140706T3 (es) Medicamentos.
NO20010277D0 (no) Benzocykloheptener, fremgangsmåte for fremstilling derav, farmasöytiske preparater inneholdende disse, og deres anvendelse for fremstilling av medikamenter
NO980858D0 (no) Farmasöytiske preparater og anordninger for administrering derav
ATE202936T1 (de) Chlorfluorkohlenwasserstoff freie aerosol- arzneizubereitungen enthaltend mometasonfuroat
NO305286B1 (no) Kinoksalinforbindelser, farmas°ytiske preparater som omfatter dem, og anvendelse derav for fremstilling av medikamenter
WO2001082868A3 (en) A medicinal aerosol formulation
NO306993B1 (no) Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler
NO308737B1 (no) Diarylalkanderivater inneholdende en alisyklisk gruppe, deres anvendelse ved fremstilling av et legemiddel, og farmasøytiske preparater inneholdende disse
DE60017450D1 (de) Pharmazeutische formulierungen enthaltend salmeterol
MX9707238A (es) Formulaciones en aerosol de butixocort.
ITBA920007A0 (it) Formulazioni farmaceutiche per la somminstrazione sistemica per via nasale degli ormoni sessuali femminili naturali e di ormoni ad attivita' estrogenica e/o progestativa sia naturali che di sintesi.
MX9707073A (es) Preparaciones de aerosol de prilocaina e hidrofluorocarbono.
AU2003300230A1 (en) Dosing aerosols containing lecithin as a surface-active substance
SI1042355T1 (en) 11beta-halogen-7alpha-substituted estratrienes, method for producing pharmaceutical preparations containing said 11beta-halogen-7alpha-substituted estratrienes and use of the same for producing medicaments